The Role of Fluconazole in the Treatment of Candida Endocarditis: A Meta-Analysis
The DOI matches its Crossref record; 90 of the 94 references it cites were found in a registry or an index.
Abstract
The treatment of Candida infective endocarditis generally involves infected valve removal accompanied by antifungal therapy with amphotericin B or a lipid-based derivative, with or without flucytosine. While often used as chronic suppressive therapy in these patients, the precise role for fluconazole has not been established. We conducted a meta-analysis of 64 literature cases of Candida endocarditis whose management did not include valve replacement but who received fluconazole, alone or concurrently or in sequence with 1 or more other antifungal drugs.Forty-nine (77%) patients were cured (n = 44) or improved (n = 5), 4 relapsed (6%), and 11 failed (10 of whom died) (17%). Among 19 patients for whom fluconazole was administered as the sole antifungal therapy, 11 (58%) were cured or improved. In contrast, among 45 patients who received 1 or more other antifungal agents in addition to fluconazole, 38 (84%) were cured or improved (p = 0.02). Eighteen of 21 (86%) patients with native valve infection were cured or improved compared with 13 of 19 (68%) patients with prosthetic valve endocarditis (p = 0.13). The mean duration of successful fluconazole regimens was 134 days. Twenty of 21 (95%) patients who received fluconazole as chronic suppressive therapy for ≥6 months were cured. Prognosis was independent of Candida species or patient age. Among 23 historical controls managed with fluconazole-containing antifungal therapy plus valvular surgery, survival was 91%.In conclusion, flu…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Moudgal, V., Little, T., Boikov, D., & Vazquez, J. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.767-769.2005 · Cited by 242 · cited 1×
“In a third patient, relapse at 3 months led to discontinuation of chronic suppressive fluconazole; he later improved and his blood cultures cleared on amphotericin B lipid complex with no further follow-up.(59) The fourth patient failed fluconazole monotherapy and no further follow-up was given.”
BackgroundCandida infective endocarditis
Baddley, J. W., Benjamin, D. K., Patel, M., Miró, J., Athan, E., Barsic, B., Bouza, E., Clara, L., Elliott, T., Kanafani, Z., et al. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0466-x · Cited by 213
Girmenia, C., Martino, P., De Bernardis, F., Gentile, G., Boccanera, M., Monaco, M., Antonucci, G., & Cassone, A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.506 · Cited by 164
Microbiological aspects ofHelicobacter pylori (Campylobacter pylori)
Goodwin, C. S., & Armstrong, J. A. (1990) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01969526 · Cited by 151
Candida Infective Endocarditis: Report of 15 Cases From a Prospective Multicenter Study
Falcone, M., Barzaghi, N., Carosi, G., Grossi, P., Minoli, L., Ravasio, V., Rizzi, M., Suter, F., Utili, R., Viscoli, C., et al. (2009) · Medicine · doi:10.1097/md.0b013e3181a693f8 · Cited by 138
Infectious Complications in Left Ventricular Assist Device Recipients
Fischer, S. A., Trenholme, G. M., Costanzo, M. R., & Piccione, W. J. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.1.18 · Cited by 123
Candida Prosthetic Valve Endocarditis: Prospective Study of Six Cases and Review of the Literature
Nguyen, M. H., Nguyen, M. L., Vu, V. L., McMahon, D., Keys, T. F., & Amidi, M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.262 · Cited by 109
Melgar, G. R., Nasser, R. M., Gordon, S. M., Lytle, B. W., Keys, T. F., & Longworth, D. L. (1997) · Medicine · doi:10.1097/00005792-199703000-00002 · Cited by 106
Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro
Odds, F. C., Cheesman, S. L., & Abbott, A. B. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.4.473 · Cited by 89
Research works printed but not linked: 2
- Pinar, 2010, Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis., Enferm Infecc Microbiol Clin, 28, 66
- Yap, 1999, Successful treatment of Candida albicans endocarditits in a child with leukemia: a case report and review of the literature., Singapore Med J, 40, 533
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
“predominate, the latter resulting in BCNIE.(199,200) Mortality is very high (.”
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
“high rate of relapse and mortality [354].”
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“After completion of this initial therapy, long-term (lifelong) suppressive therapy with an oral azole is reasonable.(243,244,246) Suppressive therapy has been used in 2 populations.”
Background2023 ESC Guidelines for the management of endocarditis
Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,754
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Metadata
- Authors
- Smego, R. A., & Ahmad, H.
- Affiliations
- Geisinger College of Health Sciences (US)
- Venue
- Medicine
- Published
- 2011-07
- Volume
- 90
- Issue
- 4
- Pages
- 237-249
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2334211593
- Semantic Scholar
- 63dc656ff2b21f91623d05890a321decd1decdb2
- Cited by
- 56
- References
- 94
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 6 · 2013: 1 · 2012: 3
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- Candida endocarditis, fluconazole, antifungal therapy, combination antifungal therapy, valve replacement, prosthetic valve endocarditis, native valve endocarditis, amphotericin B, 5-fluorocytosine, treatment outcomes
- MeSH terms
- Adult, Aged, Aged, 80 and over, Antifungal Agents, Candida albicans, Candidiasis, Dose-Response Relationship, Drug, Drug Administration Schedule, Endocarditis, Female, Humans, Male, Middle Aged, Prognosis, Recurrence, Severity of Illness Index, United States, Fluconazole, Survival Rate, Treatment Outcome, Risk Assessment, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of Fluconazole in the Treatment of Candida Endocarditis: A Meta-Analysis. https://app.cochat.ai/papers/10.1097/md.0b013e3182259d38
- The paper
- Smego, R. A., & Ahmad, H. (2011). The Role of Fluconazole in the Treatment of Candida Endocarditis: A Meta-Analysis. Medicine. https://doi.org/10.1097/md.0b013e3182259d38
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.